{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:50:41Z","timestamp":1781650241320,"version":"3.54.5"},"reference-count":26,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2014,3,17]]},"published-print":{"date-parts":[[2014,6,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background and objective<\/jats:title>\n                  <jats:p>Inflammation and endothelial dysfunction have been implicated in the pathogenesis of atherosclerotic vascular disease. Brachial artery flow-mediated dilation (FMD) is a reliable, non-invasive method of assessing endothelial function. We hypothesised that increased levels of systemic inflammatory markers are associated with impaired endothelial function as assessed by FMD in a multi-ethnic cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We assessed brachial artery FMD in 3501 participants (1739 men, 1762 women; median age 61\u2005years) in the Multi-Ethnic Study of Atherosclerosis and measured serum concentrations of interleukin (IL)-6, C reactive protein (CRP) and tumour necrosis factor (TNF)-\u03b1 receptor 1. Spearman correlation coefficients were used to evaluate the association of each inflammatory marker with FMD, adjusting for the effect of other variables associated with FMD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There was a significant inverse correlation between IL-6 levels and FMD (\u22120.042; p=0.02) after adjustment for age, gender, race\/ethnicity, education, income, low-density lipoprotein, diabetes, glucose, hypertension status and treatment, waist circumference, triglycerides, baseline brachial diameter, recent infection and use of medications that may alter inflammation. There was no significant correlation between CRP and FMD (0.008; p=0.64) or TNF-\u03b1 receptor 1 and FMD (0.014; p=0.57). There was no evidence of effect modification by race\/ethnicity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this multi-ethnic cohort, increased levels of the pro-inflammatory cytokine IL-6 were associated with impaired endothelial function assessed by FMD. Elevated IL-6 levels may reflect a state that promotes vascular inflammation and development of subclinical atherosclerosis independent of traditional cardiovascular risk factors.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2013-304893","type":"journal-article","created":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T22:03:22Z","timestamp":1396994602000},"page":"862-866","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":58,"title":["Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA)"],"prefix":"10.1136","volume":"100","author":[{"given":"Shepard D","family":"Weiner","sequence":"first","affiliation":[{"name":"Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna N","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhezhen","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Joseph P. Mailman School of Public Health, Columbia University, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Pathology, University of Vermont College of Medicine, Burlington, Vermont, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Herrington","sequence":"additional","affiliation":[{"name":"Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Clark","family":"Nelson","sequence":"additional","affiliation":[{"name":"Biostatistics Unit, Group Health Research Institute and Department of Biostatistics, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco R","family":"Di Tullio","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Homma","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,4,8]]},"reference":[{"key":"2025100703154155000_100.11.862.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.537878"},{"key":"2025100703154155000_100.11.862.2","doi-asserted-by":"publisher","DOI":"10.1161\/hc0902.104353"},{"key":"2025100703154155000_100.11.862.3","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93147-F"},{"key":"2025100703154155000_100.11.862.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207"},{"key":"2025100703154155000_100.11.862.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000012543.55874.47"},{"key":"2025100703154155000_100.11.862.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00702-4"},{"key":"2025100703154155000_100.11.862.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(96)05968-0"},{"key":"2025100703154155000_100.11.862.8","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000113708.46466.C0"},{"key":"2025100703154155000_100.11.862.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.3.327"},{"key":"2025100703154155000_100.11.862.10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050078"},{"key":"2025100703154155000_100.11.862.11","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1793"},{"key":"2025100703154155000_100.11.862.12","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000148821.97162.5E"},{"key":"2025100703154155000_100.11.862.13","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.9.1000"},{"key":"2025100703154155000_100.11.862.14","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000021125.83697.21"},{"key":"2025100703154155000_100.11.862.15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1160\/TH05-08-0571","article-title":"C-reactive protein, interluekin-6, and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population based, prospective study","volume":"95","author":"Tuomisto","year":"2006","journal-title":"Thromb Haemost"},{"key":"2025100703154155000_100.11.862.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040967"},{"key":"2025100703154155000_100.11.862.17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp115"},{"key":"2025100703154155000_100.11.862.18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.1995.tb01618.x","article-title":"Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis","volume":"54","author":"Diez-Ruiz","year":"1995","journal-title":"Eur J Haematol"},{"key":"2025100703154155000_100.11.862.19","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf113"},{"key":"2025100703154155000_100.11.862.20","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000157730.94423.4B"},{"key":"2025100703154155000_100.11.862.21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/clinchem\/41.2.264","article-title":"Laboratory methods and quality assurance in the Cardiovascular Health Study","volume":"41","author":"Cushman","year":"1995","journal-title":"Clin Chem"},{"key":"2025100703154155000_100.11.862.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.05.049"},{"key":"2025100703154155000_100.11.862.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.580233"},{"key":"2025100703154155000_100.11.862.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(03)00193-X"},{"key":"2025100703154155000_100.11.862.25","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000153272.48711.B9"},{"key":"2025100703154155000_100.11.862.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2005.10.011"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2013-304893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T10:15:49Z","timestamp":1759832149000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2013-304893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,8]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,5,8]]},"published-print":{"date-parts":[[2014,6,1]]}},"alternative-id":["10.1136\/heartjnl-2013-304893"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2013-304893","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,8]]}}}